Beacon NewsFlashes - March 27, 2009
Diamonds & Champions – On April 2, the Leukemia & Lymphoma Society (LLS) will be hosting this benefit at the Omaha Hilton Hotel in Omaha, NE from 6:30 p.m. till 10 p.m. The event includes a reception, dinner, and presentation. The presentation will highlight advances in blood cancer research and treatment. Reservations and tickets are required to attend. For more information, please visit the LLS Web site.
Dress Down Day – The Northern New Jersey chapter of the Leukemia & Lymphoma Society (LLS) is asking that on April 3 businesses allow their workers to dress down in honor of blood cancer patients in Northern New Jersey. Participants are requested to donate a minimum of $10. Donations will go towards blood cancer research, patient care, and educational programs supported by the LLS. For more information, please see the LLS Web site.
Ft. Lauderdale Regional Community Workshop – On April 11, the International Myeloma Foundation (IMF) is holding an informational workshop on multiple myeloma at the Memorial Hospital West in Pembroke Pines, FL. The workshop begins at 9 a.m. and ends at noon. Information on diagnosis, relapse, side effects of treatment, and the importance of clinical trials will be discussed by specialists in myeloma. For further information, please visit the IMF Web site.
3rd Annual Tom Burke 3-On-3 Basketball Games – On April 4, the Burke family is hosting this tournament to benefit the Leukemia & Lymphoma Society (LLS) in memory of Tom Burke. The games will be held at Iona College in New Rochelle, NY from 11 a.m. till 5 p.m. Teams may consist of 3-5 players with an entry fee of $75 per team. Pre-registration is required by April 1. For more information, please visit the LLS Web site.
Related Articles:
- Latest Myeloma Research To Be Presented At The American Society Of Clinical Oncology Annual Meeting (ASCO 2018)
- Common Measures Of Heart And Blood Vessel Health May Predict Risk Of Heart-Related Side Effects During Treatment With Kyprolis
- ECT-001 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation By U.S. FDA
- Selective Digestive Decontamination May Reduce Risk of Infection In Myeloma Patients Undergoing Autologous Stem Cell Transplants
- Number And Type Of Stem Cell Transplants Carried Out Each Year For Multiple Myeloma Vary Markedly Across U.S. Cancer Centers